The Annex 1 of the EU GMP Guide "Manufacture of Sterile Medicinal Products" is considered the most important European regulatory standard for the…
The field of drug development can be risky and a costly investment - mistakes can mean the success or failure of a compound or even a company.
How Global Trends Are Driving Patient-Centricity in Parenteral Products.
The key to successful development and guiding a drug to approval is early planning.
Fast, safe and efficient: the new Vetter ID determination of oligonucleotides.
Interview with Oskar Gold, SVP Asia Pacific and Global Emerging Markets
Why double-bagged tubs are an issue for high-speed filling lines
A CDMO’s Guide to Digitalization in the Pharmaceutical Industry
A Holistic Cleanroom Concept: Higher Quality and Greater Flexibility
Why CDMOs are increasingly vital to successful drug development
All technology transfers are high-risk. An experienced CDMO partner is critical in this challenging process.
How small production quantities are growing in importance